PE news feed

February 14, 2026

Breakthru Medicine Snares $60 Million Series A

Breakthru Medicine

Glendale, AZ 85310

Steve Potts — CEO

Breakthru Medicine focuses on aggressive solid tumors with the highest unmet need-cancers where patients have exhausted existing options. By attacking the specific molecular drivers of each tumor, we design precision therapies for patients whose cancers have become resistant to current treatments.

https://www.breakthrumed.com/

RELATED POSTS

daydream Nabs $15M Series A Round

daydream is a leading AI-native agency that delivers an unfair advantage in organic search by combining a proven methodology with SEO agents and dedicated experts through full-service support.

Alcatraz Secures $50M Series B Round

Alcatraz AI transforms access control by leveraging artificial intelligence and analytics to make powerful decisions at the edge, where your face becomes your credential. Alcatraz’s facial authentication technology and intelligent tailgating detection enable enterprises to innovate and future-proof their security strategy. Our state-of-the-art product, the Rock, is designed to be easy to deploy on any access control system, providing an enterprise-grade security solution to protect businesses, people, and assets.

Cross River Receives $50M Funding

Cross River builds technology that powers the future of financial services. Leveraging its proprietary real-time digital banking core, Cross River delivers innovative and scalable embedded payments, cards, lending and crypto solutions to millions of consumers and businesses. Cross River is backed by leading investors and serves the world’s most essential technology and fintech companies at the forefront of innovation. As a leader in the industry, Cross River is reshaping global finance and financial inclusion.